UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 111

Sortiert nach

CXCR4–CXCL12 interaction is important for plasma cell homing and survival in NZB/W mice

European journal of immunology, 2018-06, Vol.48 (6), p.1020-1029

2018

Volltextzugriff (PDF)

Immunology in rheumatology

Zeitschrift für Rheumatologie, 2023-05, Vol.82 (4), p.267-268

2023

Volltextzugriff (PDF)

Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort

Annals of the rheumatic diseases, 2021-10, Vol.80 (10), p.1306

2021

Volltextzugriff (PDF)

Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice

PloS one, 2015-08, Vol.10 (8), p.e0135081-e0135081

2015

Volltextzugriff (PDF)

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus

Annals of the rheumatic diseases, 2015-07, Vol.74 (7), p.1474-1478

2015

Volltextzugriff (PDF)

Long-lived autoreactive plasma cells drive persistent autoimmune inflammation

Nature reviews. Rheumatology, 2011-03, Vol.7 (3), p.170

2011

Volltextzugriff (PDF)

Memory B and memory plasma cells

Immunological reviews, 2010-09, Vol.237 (1), p.117-139

2010

Volltextzugriff (PDF)

IgG4-related disease

Deutsche medizinische Wochenschrift (1946), 2019-12, Vol.144 (24), p.1726

2019

Volltextzugriff (PDF)

Multicenter Delphi Exercise to Identify Important Key Items for Classifying Systemic Lupus Erythematosus

Arthritis care & research (2010), 2018-10, Vol.70 (10), p.1488-1494

2018

Volltextzugriff (PDF)

New treatments for systemic lupus erythematosus

Zeitschrift für Rheumatologie, 2020-05, Vol.79 (4), p.342

Hoyer, Bimba F

2020

Volltextzugriff (PDF)

Brief Report: How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria

Arthritis & rheumatology (Hoboken, N.J.), 2019-01, Vol.71 (1), p.91-98

2019

Volltextzugriff (PDF)

Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursors

European journal of immunology, 2018-09, Vol.48 (9), p.1573-1579

2018

Volltextzugriff (PDF)

Autoantibodies from long-lived ‘memory’ plasma cells of NZB/W mice drive immune complex nephritis

Annals of the rheumatic diseases, 2013-12, Vol.72 (12), p.2011-2017

2013

Volltextzugriff (PDF)

Secondary research use of personal medical data: patient attitudes towards data donation

BMC medical ethics, 2021-12, Vol.22 (1), p.164-164, Article 164

2021

Volltextzugriff (PDF)

Selective depletion of plasma cells in vivo based on the specificity of their secreted antibodies

European journal of immunology, 2020-02, Vol.50 (2), p.284-291

2020

Volltextzugriff (PDF)

Associations Between Classification Criteria Items in Systemic Lupus Erythematosus

Arthritis care & research (2010), 2020-12, Vol.72 (12), p.1820-1826

2020

Volltextzugriff (PDF)

Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response

Blood, 2005-02, Vol.105 (4), p.1614-1621

2005

Volltextzugriff (PDF)

Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases

Rheumatic & musculoskeletal diseases open, 2021-01, Vol.7 (1), p.e001464

2021

Volltextzugriff (PDF)

Patient Reported Outcomes in Chronic Inflammatory Diseases: Current State, Limitations and Perspectives

Frontiers in immunology, 2021-03, Vol.12, p.614653-614653

2021

Volltextzugriff (PDF)

Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab

Annals of the rheumatic diseases, 2012-01, Vol.71 (1), p.75-79

2012

Volltextzugriff (PDF)

Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice

The Journal of experimental medicine, 2004-06, Vol.199 (11), p.1577-1584

2004

Volltextzugriff (PDF)

National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD

Rheumatic & musculoskeletal diseases open, 2020-09, Vol.6 (2), p.e001332

2020

Volltextzugriff (PDF)

Plasmablasts With a Mucosal Phenotype Contribute to Plasmacytosis in Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2017-10, Vol.69 (10), p.2018-2028

2017

Volltextzugriff (PDF)

Long-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors

Arthritis research & therapy, 2015-03, Vol.17 (1), p.39-39, Article 39

2015

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(100)

Publikationsform

Sprache

Englisch
(87)
Deutsch
(31)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

CXCR4–CXCL12 interaction is important for plasma cell homing and survival in NZB/W mice

Immunology in rheumatology

Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort

Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus

Long-lived autoreactive plasma cells drive persistent autoimmune inflammation

Memory B and memory plasma cells

IgG4-related disease

Multicenter Delphi Exercise to Identify Important Key Items for Classifying Systemic Lupus Erythematosus

New treatments for systemic lupus erythematosus

Brief Report: How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria

Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursors

Autoantibodies from long-lived ‘memory’ plasma cells of NZB/W mice drive immune complex nephritis

Secondary research use of personal medical data: patient attitudes towards data donation

Selective depletion of plasma cells in vivo based on the specificity of their secreted antibodies

Associations Between Classification Criteria Items in Systemic Lupus Erythematosus

Anti‐TNF therapy impairs both short‐ and long‐term IgG responses after repeated vaccination

Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response

Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases

Patient Reported Outcomes in Chronic Inflammatory Diseases: Current State, Limitations and Perspectives

Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab

Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice

National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD

Plasmablasts With a Mucosal Phenotype Contribute to Plasmacytosis in Systemic Lupus Erythematosus

Long-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors

Suchergebnisse filtern